Compare PPIH & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPIH | ORGO |
|---|---|---|
| Founded | 1909 | 1985 |
| Country | United States | United States |
| Employees | N/A | 854 |
| Industry | Pollution Control Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.6M | 181.4M |
| IPO Year | 1994 | 2016 |
| Metric | PPIH | ORGO |
|---|---|---|
| Price | $31.83 | $1.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $36.00 | $8.50 |
| AVG Volume (30 Days) | 81.8K | ★ 594.1K |
| Earning Date | 04-16-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 86.61 | ★ 1600.00 |
| EPS | ★ 0.53 | N/A |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | $8.81 | N/A |
| Revenue Next Year | $9.33 | $26.27 |
| P/E Ratio | $58.94 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $22.13 | $1.34 |
| 52 Week High | $36.72 | $7.08 |
| Indicator | PPIH | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 72.56 | 33.35 |
| Support Level | $29.10 | $1.34 |
| Resistance Level | $33.91 | $2.69 |
| Average True Range (ATR) | 1.16 | 0.07 |
| MACD | 0.13 | 0.01 |
| Stochastic Oscillator | 100.00 | 17.65 |
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems of the company include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, the coating and insulation of oil and gas gathering and transmission pipelines, and liquid and powder based anti-corrosion coatings applied both to the external and internal surfaces of steel pipe, including shapes such as bends, reducers, tees, and other fittings.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.